An oncologist recently shared a story with us about a patient with a rare but often curable form of cancer called sarcoma. In addition to seeing their oncologist, the patient sought alternative treatment from a “wellness” clinic that…
Every year, several thousand cancer patients in Sweden risk receiving too little pain relief in the end of life, as the health care system fails to detect that the patients are suffering from pain. When patients cannot verbalize their pain…
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown.
Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center demonstrate promising responses and safety profiles in…
Doctors in Britain say that an immunotherapy drug, given before surgery, can help many more colon cancer patients with a specific genetic profile stay cancer-free long term.
A 69-year-old man was arrested in Volusia County after after he was accused of posing as a cancer patient and scamming a Florida nonprofit out of thousands of dollars.
In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone's…
A cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs, called immune checkpoint inhibitors (ICIs), are so expensive that some uninsured Americans can't access them.
(MedPage Today) -- CHICAGO -- A perioperative regimen of four cycles of chemotherapy before and after surgery extended overall survival (OS) compared with neoadjuvant chemoradiation in patients with locally-advanced, resectable esophageal…
(MedPage Today) -- CHICAGO -- Omitting lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy did not compromise outcomes and resulted in…
The immunotherapy drug, Jemperli, from GSK was given to 42 patients with locally advanced mismatch repair deficient (dMMR) rectal cancer - a form of bowel cancer
Moderna and Merck's Phase 2b study results for mRNA-4157 combined with Keytruda, showing improvements in recurrence-free and distant metastasis-free survival for high-risk melanoma patients. Phase 3 trials are now underway for melanoma and…
Scaling back treatment for three kinds of cancer can make life easier for patients without compromising outcomes, doctors reported at a cancer conference.
A new study led by investigators from Mass General Cancer Center reveals the effectiveness of more scalable ways of delivering palliative care to patients with advanced lung cancer.
AN immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100 per cent of cases.
AN immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100 per cent of cases.